Professional Documents
Culture Documents
Johnson RJ, Feehally J, Floege J, et al. Comprehensive clinical nephrology. 5th ed. Philadephia:Elsevire Saunders;2015.
Clinical approach of hyponatremia
HYPONATREMIA
Urine Na+ >20 Urine Na+ <20 Urine Na+ >20 Urine Na+ <20
mmol/l mmol/l mmol/l mmol/l
Johnson RJ, Feehally J, Floege J, et al. Comprehensive clinical nephrology. 5th ed. Philadephia:Elsevire Saunders;2015.
Management of hyponatremia
Acute Hyponatremia Chronic Hyponatremia
Setiati S, Alwi I, Sudoyo AW, et al. Buku Ajar Ilmu Penyakit Dalam. Edisi 6. Jakarta: Interna Publishing
Hypernatremia
• Definition: plasma natrium >145 mmol/L
• Dehydration (hypovolemia hypernatremia) VS
volume depletion (hypovolemia normonatremia)
• Clinical manifestations:
– CNS symptoms: altered mental status, lethargy,
irritability, restlessness, seizures (usually in children),
muscle twitching, hyperreflexia, and spasticity
– Fever, nausea or vomiting, labored breathing, and
intense thirst
Johnson RJ, Feehally J, Floege J, et al. Comprehensive clinical nephrology. 5th ed. Philadephia:Elsevire Saunders;2015.
Clinical approach of
hypernatremia HYPERNATREMIA
Urine Na+ >20 Urine Na+ <20 Variabel Urine Na+ Urine Na+ >20
mmol/l mmol/l <20 mmol/l mmol/l
Johnson RJ, Feehally J, Floege J, et al. Comprehensive clinical nephrology. 5th ed. Philadephia:Elsevire Saunders;2015.
Management of hypernatremia
Johnson RJ, Feehally J, Floege J, et al. Comprehensive clinical nephrology. 5th ed. Philadephia:Elsevire Saunders;2015.
Hypokalemia
Definition: plasma K+ < 3,5 meq/L
Etiologies of hypokalemia:
1. Decrease intake
2. Shifting of potassium into the cell: extracell alkalosis, insulin,
use of β2-agonis, hypokalemic periodic paralysis,
hypothermia
3. Excessive potassium excretion: through GI (vomitting,
diarrhea), renal (diuretics, primary hyperaldosteronism,
hypomagnesemia, polyuria, excessive sweating, etc.
Setiati S, Alwi I, Sudoyo AW, et al. Buku Ajar Ilmu Penyakit Dalam. Edisi 6. Jakarta: Interna Publishing
Clinical manifestation of hypokalemia
Setiati S, Alwi I, Sudoyo AW, et al. Buku Ajar Ilmu Penyakit Dalam. Edisi 6. Jakarta: Interna Publishing
Hyperkalemia
Definition: plasma K+ > 5 meq/L
Etiologies of hypokalemia:
Impaired excretion
• Renal failure
• mineralocorticoid deficiency
• Pseudohypoaldosteronism
• drugs (potassium sparing diuretics, ACE-
inhibitors NSAID, cyclosporin)
Shifts of K out of cells
• Tissue breakdown
• Acidosis
• insulin deficiency
Setiati S, Alwi I, Sudoyo AW, et al. Buku Ajar Ilmu Penyakit Dalam. Edisi 6. Jakarta: Interna Publishing
Clinical Manifestations
Johnson RJ, Feehally J, Floege J, et al. Comprehensive clinical nephrology. 5th ed. Philadephia:Elsevire Saunders;2015.
Management of hyperkalemia
1. Overcome hyperkalemia effect of cell
membrane:
– calcium gluconate IV
2. Return the K+ from extracellular to intracellular:
– insulin
– sodium bicarbonate
– α 2-agonist
3. Removal of excess K+:
– temporary loop diuretics
– hemodialysis (in acute setting)
Setiati S, Alwi I, Sudoyo AW, et al. Buku Ajar Ilmu Penyakit Dalam. Edisi 6. Jakarta: Interna Publishing
Calcium-
phosphate
homeostasi
s
Jain S, Kennedy P, Srinivasan R, Chaudhry S. Calcium Homeostasis and osteoporosis. McMaster Pathophysiology Review
Distribution of calcium intra and
extracellular
• 45% bound to protein (mainly albumin)
• 15% bound to other anion such as phosphate
and citrate
• 40% free form or ionized active form
Normal range:
• Plasma Ca= 8,5-10,5 mg/dl
• Ionized Ca= 4,65-5,25 mg/dl
In hypoalbumin patient:
Corrected Ca (mg/dl) = measured Ca (mg/dl) + [0.8 x (4 – albumin (g/dl))]
Setiati S, Alwi I, Sudoyo AW, et al. Buku Ajar Ilmu Penyakit Dalam. Edisi 6. Jakarta: Interna Publishing
Hypocalcemia
Definition: serum
calcium <8,5 mg/dl
Johnson RJ, Feehally J, Floege J, et al. Comprehensive clinical nephrology. 5th ed. Philadephia:Elsevire Saunders;2015.
Clinical manifestation of
hypocalcemia
• fatigue and muscular weakness
• increased irritability
• a state of confusion
• paranoia, depression
• paresthesias of the lips and the Chvostek Sign (+)
extremities
• muscle cramps seizures
• cardiac: prolonged QT interval,
hypotension, arrythmia
Trousseau Sign (+)
Johnson RJ, Feehally J, Floege J, et al. Comprehensive clinical nephrology. 5th ed. Philadephia:Elsevire Saunders;2015.
Management of hypocalcemia
• Severe symptomatic (plasma Ca ≤7.5 mg/dl):
IV calcium gluconate
• Mild to moderate (plasma Ca >7.5 mg/dl) :
oral calcium
• Hypo parathyroid: vitamin D supplementation
(calcitriol, ergocalciferol or cholecalciferol)
• Vitamin D deficiency: oral vitamin D3 50,000
IU 1x/week for 6-8 weeks, and continued with
800-1000 IU vitamin D3/day.
Setiati S, Alwi I, Sudoyo AW, et al. Buku Ajar Ilmu Penyakit Dalam. Edisi 6. Jakarta: Interna Publishing
Hypercalcemia
Definition: serum calcium >10,5 mg/dl
Clinical Manifestations
General increasing fatigue, muscle weakness, inability to concentrate,
nervousness, increased sleepiness
GI constipation, nausea and vomiting, and rarely peptic ulcer disease
or pancreatitis
Renal polyuria, urinary tract stone
Neuropsychiatric headache, loss of memory, somnolence, stupor
Ocular conjunctivitis from crystal deposition and rarely band keratopathy
Osteoarticular pain
Cardiac ECG shortening of the QT interval and coving of the ST wave
Increase cardiac contractility and amplify digitalis toxicity.
Johnson RJ, Feehally J, Floege J, et al. Comprehensive clinical nephrology. 5th ed. Philadephia:Elsevire Saunders;2015.
Etiology of Hypercalcemia
Johnson RJ, Feehally J, Floege J, et al. Comprehensive clinical nephrology. 5th ed. Philadephia:Elsevire Saunders;2015.
Management of hypercalcemia
Severe and symptomatic hypercalcemia:
– Rapid rehydration with isotonic saline to correct
volume depletion
– After euvolemia loop diuretics to facilitate
urinary excretion of calcium
• Bisphosphonates
• Corticosteroids for hypervitaminosis D
Setiati S, Alwi I, Sudoyo AW, et al. Buku Ajar Ilmu Penyakit Dalam. Edisi 6. Jakarta: Interna Publishing
Hyperphosphatemia
Definition: serum phosphate > 4.5 mg/dL
Clinical manifestation:
• Deposition of phosphate and calcium in soft
tissues
• Vascular calcification
• Block 25-hydroxyvitamin D to calcitriol induce
hypocalcemia and increase PTH
Treatment:
• In CKD phosphate binder, restriction of
phosphate diet
Johnson RJ, Feehally J, Floege J, et al. Comprehensive clinical nephrology. 5th ed. Philadephia:Elsevire Saunders;2015.
Etiology of Hyperphosphatemia
Most common cause: AKI and CKD
Johnson RJ, Feehally J, Floege J, et al. Comprehensive clinical nephrology. 5th ed. Philadephia:Elsevire Saunders;2015.
Hypophosphatemia
Definition: serum
phosphate < 2.5 mg/dL
Johnson RJ, Feehally J, Floege J, et al. Comprehensive clinical nephrology. 5th ed. Philadephia:Elsevire Saunders;2015.
Hypophosphatemia
Clinical Manifestation
• metabolic encephalopathy, red and white
blood cell dysfunction, hemolysis, and
thrombocytopenia
• reduced muscle strength (e.g., diaphragmatic
strength) and decreased myocardial
contractility
Johnson RJ, Feehally J, Floege J, et al. Comprehensive clinical nephrology. 5th ed. Philadephia:Elsevire Saunders;2015.
Magnesium homeostasis
Hypermagnesemia
Definition: serum Mg2+ > 2.6 mg/dL (> 1.05
mmol/L)
Etiology:
Johnson RJ, Feehally J, Floege J, et al. Comprehensive clinical nephrology. 5th ed. Philadephia:Elsevire Saunders;2015.
Hypermagnesemia
Clinical Manifestation:
• up to 1.5 mmol/l (3.6 mg/dl) asymptomatic
• > 3 mmol/l (7.2 mg/dl loss of deep tendon reflexes
• 5 mmol/l (12 mg/dl) respiratory paralysis, hypotension,
abnormal cardiac conduction, and loss of consciousness
Management:
• Symptomatic hypermagnesemia: calcium gluconate
Johnson RJ, Feehally J, Floege J, et al. Comprehensive clinical nephrology. 5th ed. Philadephia:Elsevire Saunders;2015.
Hypomagnesemia
Definition: serum
Mg2+ < 1.8 mg/dL
(< 0.70 mmol/L)
Johnson RJ, Feehally J, Floege J, et al. Comprehensive clinical nephrology. 5th ed. Philadephia:Elsevire Saunders;2015.
Hypomagnesemia
Clinical manifestation:
• general weakness and neuromuscular
hyperexcitability with hyperreflexia
• carpopedal spasm, seizure, tremor, and rarely
tetany
• ECG: prolonged QT interval and ST depression
Treatment:
• Magnesium sulfate for parenteral therapy, 1500
to 3000 mg/day
Johnson RJ, Feehally J, Floege J, et al. Comprehensive clinical nephrology. 5th ed. Philadephia:Elsevire Saunders;2015.